Why Did Canada Goose (TSX:GOOS) Stock Surge 57%?

Canada Goose (TSX:GOOS)(NYSE:GOOS) stock was crushed during the initial coronavirus correction. But right now, shares are surging higher.

| More on:
stocks rising

Image source: Getty Images

Canada Goose (TSX:GOOS)(NYSE:GOOS) stock is wild.

At the start of 2020, shares were priced at $50. When COVID-19 hit, the stock cratered to $20. The market worried that shares would continue sinking for months to come.

Then something incredible happened: Canada Goose stock surged back towards the $50 mark. The stock is now closing in on multi-year highs.

What caused this sudden rebound?

Investors were skeptical

Canada Goose stock was falling even before the pandemic hit. In 2018, shares were priced above $90. By the start of 2019, they were valued at $60.

The fall wasn’t due to weak results as much as overly optimistic expectations. When the company first went public, shares tripled in just 18 months. The market fell in love with the stock, sending the valuation soaring above 100 times earnings.

As with many growth stocks, expectations eventually came down to earth. Canada Goose was still growing earnings by 30% per year at the start of 2019, but the valuation multiple was simply too high, forcing a brief correction.

If it weren’t for the pandemic, shares would have been a bargain. Unfortunately, the COVID-19 situation hit Canada Goose where it was weakest: China.

Roughly one-third of the company’s sales come from Canada. Another third comes from the United States. The rest come from international locations, with China being the biggest opportunity. That country is the biggest luxury market in the world — a perfect fit for Canada Goose’s $1,000 high-end jackets.

You likely know that the coronavirus began in China, sending retail sales growth off a cliff. That’s why shares plummeted from $50 to $20.

But why has the stock rebounded?

Will Canada Goose rise more?

If you want to bet on this stock, you must understand the recent rebound.

Shares were overpriced in 2018, but this summer, sentiment swung too hard the other way. In August, I’d suggested shares were a buy due to valuation.

“Of course, COVID-19 began in China, hitting retail sales hard. However, the worst may be behind us,” I explained.

At the time, Canada Goose executives were already claiming that growth in China was picking up.

“Overall, the retail recovery in Mainland China is ahead of other regions, and so serving the world’s largest luxury consumer at home has become increasingly crucial,” its CEO revealed. “We believe that our strategic approach to growing our Mainland China DTC business this year has us very much on the right track.”

It took a few months for the market to catch on, but Canada Goose had become a growth stock again. The valuation multiple compressed from 100 times earnings to just 20 times earnings, yet sales and profits were still expected to grow by 20% annually. That was a mismatch worth buying.

There’s only one question left: Is there still time to bet on Canada Goose?

If you’re a long-term holder, this stock still has more to give. Domestic sales continue to grow — an impressive feat considering the company has industry-leading margins.

Looking further out, Canada Goose could triple in size based on international expansion alone. Just know this will take a few years to play out.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

The Motley Fool owns shares of and recommends Canada Goose Holdings. Fool contributor Ryan Vanzo has no position in any stocks mentioned.

More on Coronavirus

rail train
Coronavirus

Bull or Bear: Why Analysts Changed Their Tune on Aecon Stock

Analysts had been champing at the bit for the construction company, but the tides have turned.

Read more »

Biotech stocks
Coronavirus

Is Bellus Health Stock Still a Buy After 30% Earnings Jump?

The biotech continues to make progress on obtaining FDA approval for its chronic-cough therapy.

Read more »

grow dividends
Coronavirus

Goodfood Stock Likely to Double in 2022!

Goodfood (TSX:FOOD) stock has had a huge rise and fall in the last few years. But at $1.85 a share,…

Read more »

grow dividends
Coronavirus

Canfor Stock Pops 5% as Sales Climb 15% YOY

Canfor (TSX:CFP) stock remained positive about its future in the global lumber market after profits climb 15% year over year.

Read more »

edit Safety First illustration
Coronavirus

2 Crash-Proof TSX Stocks I’d Buy With $5,000

These two TSX stocks have proven they can handle this economic downturn and likely will continue to be safe far…

Read more »

TSX Today
Coronavirus

What to Watch on the TSX on Tuesday, April 26

Earnings continue to come out on the TSX today, including Air Canada (TSX:AC). Meanwhile, investors may want to continue watching…

Read more »

think thought consider
Coronavirus

Should Investors Buy Goodfood Stock Ahead of Earnings?

Goodfood (TSX:FOOD) stock dropped on Wednesday ahead of the company's earnings release. And it's unclear whether there will be anything…

Read more »

little girl in pilot costume playing and dreaming of flying over the sky
Coronavirus

Cargojet Stock Soars Higher, Is it Still a Buy?

Cargojet stock (TSX:CJT) jumped after its deal with DHL, but at today's prices is the airline company still a buy…

Read more »